Breast reconstruction products aim to restore a natural breast shape and volume after mastectomy or breast cancer surgery. These products involve breast implants filled with saline or silicone gel to reconstruct breast shape. Tissue expanders are also used which help grow new skin and tissue before implantation of a breast implant. The breast reconstruction market has gained importance due to the growing cases of breast cancer and increasing awareness regarding breast reconstructive procedures after mastectomy. Breast reconstructive surgeries enhance confidence and quality of life among women treated for breast cancer.

The global Breast Reconstruction Market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The increasing incidences of breast cancer cases is one of the key opportunities augmenting the demand for effective breast reconstruction treatments. According to the American Cancer Society, breast cancer accounts for 30% of all new cancer cases diagnosed in American women annually. Reconstruction after mastectomy is important to reclaim physical well-being, emotional balance, and support healing. Breast reconstruction treatments aim to rebuild breasts to closely match the dimensions, appearance, and sensation of the unfettered breast. Thus, the rising prevalence of breast cancer and increasing awareness regarding reconstruction is expected to drive the breast reconstruction market growth over the forecast period.

Porter's Analysis
Threat of new entrants: Low as this market requires huge investment in R&D and clinical trials. Also existing players have strong brand name.

Bargaining power of buyers: Moderate as buyers have many options and cheaper substitutes available.

Bargaining power of suppliers: Low as raw material suppliers have limited power on manufacturers and brand owners.

Threat of new substitutes: Moderate as non-invasive breast enhancements are emerging as alternatives.

Competitive rivalry: High due to presence of major players and regional players offering differentiated products.

SWOT Analysis

Strengths: Increasing breast cancer cases and technological advancements in reconstruction methods.

Weaknesses: High cost associated and longer recovery time required for reconstruction surgeries. Lack of awareness in developing nations.

Opportunities: Emergence of breast size reduction market and untapped markets in developing regions.

Threats: Social stigma associated and preference of non-invasive/natural methods over reconstructions. Stringent regulations.

Key Takeaways

The Global Breast Reconstruction Market Size is expected to witness high growth during the forecast period owing to increasing prevalence of breast cancer worldwide. North America dominates the global market due to growing awareness about breast reconstruction surgeries and favorable reimbursement policies in the region. Europe holds a substantial share due to rising government focus on women's healthcare.

Key players operating in the Breast Reconstruction market are Mentor Medical Systems B.V. (Johnson & Johnson),,Allergan, Inc. (AbbVie),,Sientra, Inc.,,Ideal Implant Incorporated,,Establishment Labs,,POLYTECH Health & Aesthetics GmbH,,RTI Surgical,,Sebbin,,Integra LifeSciences,,GC Aesthetics. Major players are focusing on developing innovative reconstruction solutions and geographical expansion into emerging regions.

The Asia Pacific region is expected to witness lucrative growth during the forecast period owing to increasing incidences of breast cancer, rising medical tourism, and growing awareness through initiatives by key players and government organizations. Rapid digitization in healthcare infrastructure further propels the market growth in developing Asian countries.
​
For More Insights, Read: https://www.trendingwebwire.com/breast-reconstruction-market-demand-growth-and-regional-outlook-by-2030/